NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
31/12/2024
Voltar para busca
Dado oficial do USPTO
ELISPHYRE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ELISPHYRE
ST13
US500000088832104Classe
5, 9, 10
Pedido
88832104
Registro
7629138
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
31/12/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10
Data de depósito
12/03/2020
Data de registro
31/12/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/12/2024
Última transação
31/12/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Hellerup, DK
Examinador
HOPKINS, SARAH COLLEEN
Unidade examinadora
N50
Localização atual
INTENT TO USE SECTION
Titulares e representantes
Titulares
Ascendis Pharma Bone Diseases A/S
Representantes
Shannon Marie McKeon DYKEMA GOSSETT PLLC
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of growth disorderspharmaceutical preparations for the treatment of endocrine disorderspharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical usediagnostic preparations for identifying and detecting hypoparathyroidismendocrine disorders and bone disorders
Classe 9
Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatmentpatient assistance and health insurance in the field of hypoparathyroidismgrowth disordersendocrine disorders and bone disorders; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersa downloadable software application for sharing information related to hypoparathyroidismgrowth disordersendocrine disorders and bone disorders and the treatment of hypoparathyroidismgrowth disordersendocrine disordersbone disorders for use by patients with growth hormone disordershypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidismgrowth disordersendocrine disorders and bone disorders; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersdownloadable software that coordinates the delivery of health care services between health care providerspatients and those parties responsible for the payment of health care servicesdownloadable software that allows individuals seeking medical educationinformation and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersdownloadable software that enables health care providers to monitor patientscommunicate clinical information relevant to a patient's careprovide and exchange information concerning patients and the health care services provided to patients; downloadable softwaredownloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable softwaredownloadable software applications and downloadable mobile applications for the measurement of heightweightblood pressureserum calciumblood glucoseheart rate; downloadable softwaredownloadable software applications and downloadable mobile applications for providingexchangingretrieving and analyzing health and healthcare information; downloadable software for medical purposesfor formattingviewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersa downloadable software application for providing healthcare-related informationmedication reminderstracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of hypoparathyroidismgrowth disordersendocrine disorders and bone disorders
Classe 10
Medical devices for injectiondosage and control of pharmaceuticalsmedical devices for injectiondosage measurement and monitoring of pharmaceuticals for the treatment of hypoparathyroidismgrowth disordersendocrine disorders and bone disorders; syringes for medical purposes and for injections; syringes for injection for medical and surgical usesyringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disordershypoparathyroidism and skeletal dysplasia; medical apparatusinfusion and injection devices for administering drugs; medical apparatus for diagnostic purposesmedicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
31/12/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
10/12/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
26/08/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
26/08/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29/02/2024
EX5G
SOU EXTENSION 5 GRANTED
28/02/2024
EXT5
SOU EXTENSION 5 FILED
28/02/2024
EEXT
SOU TEAS EXTENSION RECEIVED
28/02/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/09/2023
EX4G
SOU EXTENSION 4 GRANTED
30/08/2023
EXT4
SOU EXTENSION 4 FILED
30/08/2023
EEXT
SOU TEAS EXTENSION RECEIVED
30/08/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24/02/2023
EX3G
SOU EXTENSION 3 GRANTED
22/02/2023
EXT3
SOU EXTENSION 3 FILED
22/02/2023
EEXT
SOU TEAS EXTENSION RECEIVED
22/02/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25/08/2022
EX2G
SOU EXTENSION 2 GRANTED
23/08/2022
EXT2
SOU EXTENSION 2 FILED
23/08/2022
EEXT
SOU TEAS EXTENSION RECEIVED
23/08/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
26/01/2022
EX1G
SOU EXTENSION 1 GRANTED
24/01/2022
EXT1
SOU EXTENSION 1 FILED
24/01/2022
EEXT
SOU TEAS EXTENSION RECEIVED
24/01/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
31/08/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/07/2021
PUBO
PUBLISHED FOR OPPOSITION
06/07/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/06/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/06/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
26/05/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/05/2021
GNSL
LETTER OF SUSPENSION E-MAILED
03/05/2021
CNSL
SUSPENSION LETTER WRITTEN
03/05/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/03/2021
ALIE
ASSIGNED TO LIE
11/03/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/12/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/06/2020
GNRT
NON-FINAL ACTION E-MAILED
09/06/2020
CNRT
NON-FINAL ACTION WRITTEN
09/06/2020
DOCK
ASSIGNED TO EXAMINER
04/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/03/2020
NWAP
NEW APPLICATION ENTERED
16/03/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ELISPHYRE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.